Hogg RS - Search Results

1

Using observational data to emulate a randomized trial of dynamic treatment-switching strategies: an application to antiretroviral therapy.

Cain LE, Saag MS, Petersen M, May MT, Ingle SM, Logan R, Robins JM, Abgrall S, Shepherd BE, Deeks SG, John Gill M, Touloumi G, Vourli G, Dabis F, Vandenhende MA, Reiss P, van Sighem A, Samji H, Hogg RS, Rybniker J, Sabin CA, Jose S, Del Amo J, Moreno S, Rodríguez B, Cozzi-Lepri A, Boswell SL, Stephan C, Pérez-Hoyos S, Jarrin I, Guest JL, D'Arminio Monforte A, Antinori A, Moore R, Campbell CN, Casabona J, Meyer L, Seng R, Phillips AN, Bucher HC, Egger M, Mugavero MJ, Haubrich R, Geng EH, Olson A, Eron JJ, Napravnik S, Kitahata MM, Van Rompaey SE, Teira R, Justice AC, Tate JP, Costagliola D, Sterne JA, Hernán MA; Antiretroviral Therapy Cohort Collaboration, the Centers for AIDS Research Network of Integrated Clinical Systems, and the HIV-CAUSAL Collaboration. Cain LE, et al. Among authors: hogg rs. Int J Epidemiol. 2016 Dec 1;45(6):2038-2049. doi: 10.1093/ije/dyv295. Int J Epidemiol. 2016. PMID: 26721599 Free PMC article.

2

"Discordant" increases in CD4 cell count relative to plasma viral load in a closely followed cohort of patients initiating antiretroviral therapy.

Wood E, Hogg RS, Yip B, Tyndall MW, Sherlock CH, Harrigan RP, O'Shaughnessy MV, Montaner JS. Wood E, et al. Among authors: hogg rs. J Acquir Immune Defic Syndr. 2002 Jun 1;30(2):159-66. doi: 10.1097/00042560-200206010-00004. J Acquir Immune Defic Syndr. 2002. PMID: 12045678 Clinical Trial.

3

No association between GB virus-C viremia and virological or immunological failure after starting initial antiretroviral therapy.

Brumme ZL, Chan KJ, Dong WW, Mo T, Wynhoven B, Hogg RS, Montaner JS, O'Shaughnessy MV, Harrigan PR. Brumme ZL, et al. Among authors: hogg rs. AIDS. 2002 Sep 27;16(14):1929-33. doi: 10.1097/00002030-200209270-00010. AIDS. 2002. PMID: 12351953

4

Incidence of morphological and lipid abnormalities: gender and treatment differentials after initiation of first antiretroviral therapy.

Heath KV, Chan KJ, Singer J, O'Shaughnessy MV, Montaner JS, Hogg RS. Heath KV, et al. Among authors: hogg rs. Int J Epidemiol. 2002 Oct;31(5):1016-20. doi: 10.1093/ije/31.5.1016. Int J Epidemiol. 2002. PMID: 12435777

5

Influence of polymorphisms within the CX3CR1 and MDR-1 genes on initial antiretroviral therapy response.

Brumme ZL, Dong WW, Chan KJ, Hogg RS, Montaner JS, O'Shaughnessy MV, Harrigan PR. Brumme ZL, et al. Among authors: hogg rs. AIDS. 2003 Jan 24;17(2):201-8. doi: 10.1097/00002030-200301240-00010. AIDS. 2003. PMID: 12545080

6

Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy?

Wood E, Hogg RS, Yip B, Harrigan PR, O'Shaughnessy MV, Montaner JS. Wood E, et al. Among authors: hogg rs. AIDS. 2003 Mar 28;17(5):711-20. doi: 10.1097/00002030-200303280-00009. AIDS. 2003. PMID: 12646794

7

Prevalence and clinical implications of insertions in the HIV-1 p6Gag N-terminal region in drug-naive individuals initiating antiretroviral therapy.

Brumme ZL, Chan KJ, Dong WW, Wynhoven B, Mo T, Hogg RS, Montaner JS, O'Shaughnessy MV, Harrigan PR. Brumme ZL, et al. Among authors: hogg rs. Antivir Ther. 2003 Apr;8(2):91-6. Antivir Ther. 2003. PMID: 12741620

8

Rates of disease progression among human immunodeficiency virus-infected persons initiating multiple-drug rescue therapy.

Lee N, Hogg RS, Yip B, Harrigan PR, Harris M, O'Shaughnessy MV, Montaner JS. Lee N, et al. Among authors: hogg rs. J Infect Dis. 2003 Jul 1;188(1):137-41. doi: 10.1086/375781. Epub 2003 Jun 23. J Infect Dis. 2003. PMID: 12825182

9

Interventional cardiovascular procedures among HIV-infected individuals on antiretroviral therapy 1995-2000.

Braitstein P, Yip B, Heath KV, Levy AR, Montaner JS, Humphries K, Kiely FM, O'Shaughnessy MV, Hogg RS. Braitstein P, et al. Among authors: hogg rs. AIDS. 2003 Sep 26;17(14):2071-5. doi: 10.1097/00002030-200309260-00008. AIDS. 2003. PMID: 14502010

10

Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.

Bedell R, Heath KV, Hogg RS, Wood E, Press N, Yip B, O'Shaughnessy MV, Montaner JS. Bedell R, et al. Among authors: hogg rs. Antivir Ther. 2003 Oct;8(5):379-84. Antivir Ther. 2003. PMID: 14640384

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

593 results

Search Page

Filters